| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Zynx Health, a subsidiary of Hearst Corporation, is the market leader in providing evidence-based and experience-based clinical decision support solutions proven to measurably improve the quality, safety, and efficiency of patient care.
Anulex Technologies is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Airsys is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Family Care Spcalists Med Corp is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Los Angeles, CA. To find more information about Family Care Spcalists Med Corp, please visit www.fcsmg.com